CO6300849A2 - Compuesto (r)-n*6*-etil-6,7-dihidro-5h-indeno(5,6-d)tiazol-2,6-diamina y su uso como antipsicotico - Google Patents
Compuesto (r)-n*6*-etil-6,7-dihidro-5h-indeno(5,6-d)tiazol-2,6-diamina y su uso como antipsicoticoInfo
- Publication number
- CO6300849A2 CO6300849A2 CO10105401A CO10105401A CO6300849A2 CO 6300849 A2 CO6300849 A2 CO 6300849A2 CO 10105401 A CO10105401 A CO 10105401A CO 10105401 A CO10105401 A CO 10105401A CO 6300849 A2 CO6300849 A2 CO 6300849A2
- Authority
- CO
- Colombia
- Prior art keywords
- compound
- diamine
- tiazol
- dihidro
- etil
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1.- Un compuesto o una de sus sales farmacéuticamente aceptables, donde el compuesto se corresponde con la estructura de Fórmula I:2.- Una composición, donde la composición comprende un compuesto o sal farmacéuticamente aceptable de la reivindicación 1.3.- Una composición de la reivindicación 2, donde la composición comprende una cantidad terapéuticamente eficaz de un compuesto de Fórmula 1 o una de sus sales farmacéuticamente aceptables.4.- Un método para preparar el compuesto o sal de la reivindicación 1, donde el método comprende hacer reaccionar la N-((R)-6-etilamino-6,7-dihidro-5H-[-indeno[5,6-d]tiazol-2-il)-benzamida.2HBr con ácido bromhídrico en condiciones tales para obtener (R)-N*6* -etil-6,7-dihidro-5H-indeno[5.6-d]tiazol-2,6-diamina.2HBr.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3033208P | 2008-02-21 | 2008-02-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO6300849A2 true CO6300849A2 (es) | 2011-07-21 |
Family
ID=40985770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO10105401A CO6300849A2 (es) | 2008-02-21 | 2010-08-26 | Compuesto (r)-n*6*-etil-6,7-dihidro-5h-indeno(5,6-d)tiazol-2,6-diamina y su uso como antipsicotico |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20090215841A1 (es) |
| EP (1) | EP2254876A4 (es) |
| JP (1) | JP2011512407A (es) |
| KR (1) | KR20100122487A (es) |
| CN (1) | CN101952266A (es) |
| AR (1) | AR070618A1 (es) |
| AU (1) | AU2009215920A1 (es) |
| BR (1) | BRPI0907158A2 (es) |
| CA (1) | CA2716215A1 (es) |
| CL (1) | CL2009000392A1 (es) |
| CO (1) | CO6300849A2 (es) |
| CR (1) | CR11639A (es) |
| DO (1) | DOP2010000257A (es) |
| EA (1) | EA201001095A1 (es) |
| EC (1) | ECSP10010412A (es) |
| IL (1) | IL206817A0 (es) |
| MX (1) | MX2010008923A (es) |
| NI (1) | NI201000141A (es) |
| PE (1) | PE20091566A1 (es) |
| SA (1) | SA109300120B1 (es) |
| TW (1) | TW200940516A (es) |
| UY (1) | UY31668A1 (es) |
| WO (1) | WO2009105026A1 (es) |
| ZA (1) | ZA201004800B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017219808A1 (zh) * | 2016-06-21 | 2017-12-28 | 浙江柏拉阿图医药科技有限公司 | 丙型肝炎病毒抑制剂及应用 |
| CN109134600B (zh) * | 2017-06-19 | 2021-07-20 | 杭州国谋生物科技有限公司 | 作为丙型肝炎抑制剂的烷基及杂环化合物及其在药物中的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9802360D0 (sv) * | 1998-07-01 | 1998-07-01 | Wikstroem Hakan Vilhelm | New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins ((basic)-N-substituted and (basic)-N,N-disubstituted derivatives of 2,6-diamino-thiazolo(4,5-f)indan and 2,7-di-amino-thiazolo(4,5-g)tetralin |
| WO2005084205A2 (en) * | 2004-02-27 | 2005-09-15 | Teva Pharmaceutical Industries, Ltd. | Diamino thiazoloindan derivatives and their use |
-
2009
- 2009-02-18 SA SA109300120A patent/SA109300120B1/ar unknown
- 2009-02-19 US US12/388,548 patent/US20090215841A1/en not_active Abandoned
- 2009-02-20 WO PCT/SE2009/050188 patent/WO2009105026A1/en active Application Filing
- 2009-02-20 EA EA201001095A patent/EA201001095A1/ru unknown
- 2009-02-20 BR BRPI0907158-0A patent/BRPI0907158A2/pt not_active IP Right Cessation
- 2009-02-20 MX MX2010008923A patent/MX2010008923A/es not_active Application Discontinuation
- 2009-02-20 KR KR1020107018569A patent/KR20100122487A/ko not_active Application Discontinuation
- 2009-02-20 EP EP09711581A patent/EP2254876A4/en not_active Withdrawn
- 2009-02-20 AU AU2009215920A patent/AU2009215920A1/en not_active Abandoned
- 2009-02-20 JP JP2010547592A patent/JP2011512407A/ja active Pending
- 2009-02-20 CL CL2009000392A patent/CL2009000392A1/es unknown
- 2009-02-20 CN CN2009801061103A patent/CN101952266A/zh active Pending
- 2009-02-20 UY UY031668A patent/UY31668A1/es not_active Application Discontinuation
- 2009-02-20 TW TW098105543A patent/TW200940516A/zh unknown
- 2009-02-20 CA CA2716215A patent/CA2716215A1/en not_active Abandoned
- 2009-02-20 AR ARP090100601A patent/AR070618A1/es not_active Application Discontinuation
- 2009-02-20 PE PE2009000253A patent/PE20091566A1/es not_active Application Discontinuation
-
2010
- 2010-07-05 IL IL206817A patent/IL206817A0/en unknown
- 2010-07-07 ZA ZA2010/04800A patent/ZA201004800B/en unknown
- 2010-08-20 CR CR11639A patent/CR11639A/es not_active Application Discontinuation
- 2010-08-20 DO DO2010000257A patent/DOP2010000257A/es unknown
- 2010-08-20 NI NI201000141A patent/NI201000141A/es unknown
- 2010-08-20 EC EC2010010412A patent/ECSP10010412A/es unknown
- 2010-08-26 CO CO10105401A patent/CO6300849A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US20090215841A1 (en) | 2009-08-27 |
| EA201001095A1 (ru) | 2011-04-29 |
| CL2009000392A1 (es) | 2010-09-24 |
| EP2254876A1 (en) | 2010-12-01 |
| ZA201004800B (en) | 2012-06-27 |
| MX2010008923A (es) | 2010-09-07 |
| BRPI0907158A2 (pt) | 2015-07-07 |
| TW200940516A (en) | 2009-10-01 |
| IL206817A0 (en) | 2010-12-30 |
| JP2011512407A (ja) | 2011-04-21 |
| KR20100122487A (ko) | 2010-11-22 |
| AR070618A1 (es) | 2010-04-21 |
| PE20091566A1 (es) | 2009-11-06 |
| CA2716215A1 (en) | 2009-08-27 |
| CN101952266A (zh) | 2011-01-19 |
| DOP2010000257A (es) | 2010-10-31 |
| EP2254876A4 (en) | 2012-10-31 |
| NI201000141A (es) | 2011-03-24 |
| SA109300120B1 (ar) | 2011-10-08 |
| ECSP10010412A (es) | 2010-09-30 |
| AU2009215920A1 (en) | 2009-08-27 |
| CR11639A (es) | 2010-10-05 |
| UY31668A1 (es) | 2009-09-30 |
| WO2009105026A1 (en) | 2009-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR052404A1 (es) | Hidratos y polimorfos de 4-(((7r)-8-ciclopentil-7-etil-5,6,7,8-tetrahidro-5-metil-6-oxo-2-pteridinil)amino)-3- metoxi-n-(1-metil-4-piperidinil)-benzamida, procedimiento para su preparacion y su uso como farmaco | |
| CL2009000771A1 (es) | Proceso para preparar una suspensión de la sal del ácido metanosulfónico de etexilato de dabigatran en talco e hidroxipropilcelulosa en isopropoanol a 30 grados; la suspensión que se obtiene; su uso para preparar pellets de dicho metanosulfonato; y los pellets que se obtienen | |
| CY1111170T1 (el) | Ενωσεις διαρυλ αιθερα ουριας | |
| NZ607794A (en) | N-acylsulfonamide apoptosis promoters | |
| CR20160465A (es) | Polimorfo b de la n-(2-aminofenil)-4-[n-(piridin-3-il) metoxicarbonilamino-metil] benzamida (ms-275) | |
| PE20142316A1 (es) | DERIVADOS DE SULFONAMIDA COMO AGENTES INDUCTORES DE APOPTOSIS CON SELECTIVIDAD POR Bcl-2 PARA EL TRATAMIENTO DE CANCER Y ENFERMEDADES INMUNES | |
| EA200700096A1 (ru) | Производные 2-карбамид-4-фенилтиазола, способ их получения и их применение в терапии | |
| RS53617B1 (en) | NEW UNITS USEFUL FOR TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES | |
| AR051796A1 (es) | Derivados de hidantoina como inhibidores de metaloproteinasas | |
| EA201170921A1 (ru) | Фармацевтическая композиция | |
| ECSP10010192A (es) | 5-[(3,3,3-trifluoro-2-hidroxi-1-arilpropil)amino]-1h-quinolin-2-onas, un proceso para su producción y su uso como agentes antiinflamatorios | |
| NO20083708L (no) | 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer | |
| AR067770A1 (es) | Derivados de tiazol y ditiazol para el tratamiento de diabetes | |
| MY146084A (en) | Benzyl amines, a process for their production and their use as anti-inflammatory agents | |
| AR090592A1 (es) | Sales de 5-[(1r)-2-({2-[4-(2,2-difluoro-2-feniletoxi)fenil]etil}amino)-1-hidroxietil]-8-hidroxiquinolin-2(1h)-ona | |
| AR051797A1 (es) | Derivados de hidantoina inhibidores de metaloproteinasas | |
| BR112012017188A8 (pt) | composto agonista de mglu2, sua composição farmacêutica e seu uso | |
| PE20080949A1 (es) | Azolilmetiloxiranos, su uso para combatir hongos fitopatogenos, asi como productos que los contienen | |
| CL2011001829A1 (es) | 3'-n-desmetil-4''-o-(2-dietilaminoetanoil)-6-o-metil-9a-aza-9a-homoeritromicina a, sus sales y formas cristalinas 1, 2 y 3; proceso de preparacion; uso para tratar enfermedades inflamatorias; composicion farmaceutica; y composicion que ademas comprende otro compuesto activo. | |
| CO6300849A2 (es) | Compuesto (r)-n*6*-etil-6,7-dihidro-5h-indeno(5,6-d)tiazol-2,6-diamina y su uso como antipsicotico | |
| PE20090445A1 (es) | Inhibidores de produccion de beta amiloide | |
| BRPI0413500A (pt) | compostos, processos para a sua preparação, composição farmacêutica que compreende os mesmos, utilização de um composto, métodos para o tratamento e profilaxia de artrite, diabetes, distúrbios alimentares e obesidade | |
| WO2011047055A3 (en) | Novel mek inhibitors, useful in the treatment of diseases | |
| AR074592A1 (es) | Formas cristalinas de un compuesto 3-carboxipropil-aminotetralina, procesos e intermediario para su sintesis y su uso en el tratamiento de una enfermedad mediada por un antagonista de los receptores mu opioides. | |
| EA201301136A3 (ru) | Новый способ синтеза (2e)-3-(3,4-диметоксифенил)проп-2-еннитрила, применение в синтезе ивабрадина и его фармацевтически приемлемых кислотно-аддитивных солей |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Application granted | ||
| FD | Application lapsed |